Community Leaders Unite to Provide Support and Resources for Thousands of Utahns with Rare Diseases
February 21, 2023 11:00 ET | Source: Recursion Pharmaceuticals
Salt Lake City, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) — Rare Disease advocacy organizations and biotech and healthcare industry leaders will partner to accelerate the diagnosis and improve the care of more than 344,000 Utahns living with a rare disease. On Rare Disease Day, Feb. 28, 2023, community leaders will host a free event from 5 to 7 p.m. at Recursion Headquarters, 41 South Rio Grande Street in Salt Lake City to provide support and resources for those living or impacted by a rare disease. Additionally, Gov. Spencer J. Cox will declare February 28, 2023 Rare Disease Day in the State of Utah.
Rare disease is considered a condition with less than 200,000 patients. More than 10,000 rare diseases are known, most of which are genetic in nature. An estimated one in ten people in the United States have a rare disease. Today, 95 percent of rare diseases have no treatment.
The Utah Rare Disease Day event will raise awareness for rare and undiagnosed diseases and the lifelong impact they have on patients and their families – while highlighting progress in diagnosis and treatment discovery. Organizers will recognize advocates who have been instrumental in building Utah’s rare disease community and have dedicated themselves to support this important work.
“The Beehive State is buzzing with activity to address the needs of patients with rare diseases. From the use of artificial intelligence to cutting-edge genomics, the state is fertile ground for innovation to drive needed advances,” said Charlene Son Rigby, CEO of Global Genes. “By joining with patient organizations, drug developers, and researchers in Utah to mark Rare Disease Day, we hope to raise awareness about these conditions and the collaborative efforts essential to improving the lives of rare disease patients and their families.”
“There is an urgency for diagnoses, treatment and cures for the rare disease community,” said Gina Zanik, co-founder and executive director of Rare and Undiagnosed Network and Vice Chair of the Utah Rare Disease Advisory Council. “The diagnostic odyssey for someone with a rare disease takes on average seven years. We must shorten the length of the diagnostic journey and come together to support patients and their families throughout the duration.”
Rare Disease Day is an annual observance on the last day of February. A series of events will be held globally to raise awareness, strengthen the rare disease community, and advocate for needed changes to improve the lives of the 400 million people around the world who suffer from these conditions.
Rare disease patients will come together with the RARE and Undiagnosed Network (RUN), Aware of Angels, Global Genes, RARE-X, BioHive, Recursion, Metrodora Institute, ARUP, BioUtah, the University of Utah and the Rare Disease Advisory Council (RDAC) for the Rare Disease Day gathering. The coalition of organizations represents Utah’s strong collaborative ecosystem dedicated to coordinating, advocating, and promoting the interest of those living with rare diseases.
One company in this collaborative ecosystem is Recursion, a Salt Lake based biotech which is reimagining drug discovery and development through the integration of advances in biology, chemistry, automation, data science, and engineering.
“Recursion was founded to reinvent the drug development and discovery process with an early focus on rare diseases,” said Chris Gibson, Co-Founder and CEO of Recursion. “The status quo is failing to meet the needs of millions of patients with rare diseases and we are harnessing technologies like artificial intelligence to accelerate the process of bringing new therapies to patients who need them.”
For additional information visit Rare Disease Day in Utah.
Tags
rare disease salt lake city rare disease day
Related Links
Contact Data
Ryan Kelly Recursion Pharmaceuticals 610-442-1896 ryan.kelly@recursionpharma.com Gina Zanik Rare and Undiagnosed Network (RUN) (310) 883-4353 ginaszajnuk@gmail.com Tom Hume Global Genes tom.hume@globalgenes.org